F Pandolfi
Policlinico Umberto I
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by F Pandolfi.
Digestive Diseases and Sciences | 1997
Isabella Quinti; Diaa El Salman; Mohamed K. Monier; Barbara G. Hackbart; Magdi S. Darwish; Dina El-Zamiaty; Roberto Paganelli; F Pandolfi; Ray R. Arthur
The diagnostics of community-acquired acute HCVhepatitis in an endemic area was studied in 110 Egyptianpatients with acute jaundice. In the first week of thejaundiced period 30 of 110 patients (27.3%) had anti-HCVantibodies. The majority already showed high levels ofanti-HCV IgG (25/30), associated with anti-HCV IgM innine of them. Five patients showed only an HCV IgMreactivity. Seven had also anti-HEV and/or anti-HBV: their jaundice couldthen be related to an acute infection caused by thoseviruses. All patients were infected with genotype 4a, inthree associated with the 3a. During the follow-up five patients seroconverted for IgG, whiletheir anti-HCV IgM did not show a uniform pattern ofreactivity. Patients with positive serology suspected ofan acute HCV infection were older than the patients with other acute hepatitis and showed a lowerpeak of ALT level. Seroconversion during acute hepatitisstrongly indicated HCV as the etiologic agent. However,the detection of anti-HCV IgG antibodies in the jaundiced period showed that the majorityof patients had already seroconverted to anti-HCVantibodies; in most of them it is possible tohypothesize a reactivation of a chronic HCVinfection.
Acta Haematologica | 1984
I Quinti; Leonardo Pacilli; V. Zoli; Giuliana De Sanctis; E. Mannella; G. Bonomo; A. De Laurenzi; F Pandolfi
We report the case of a 70-year-old female with a lymphocytosis which was casually detected during a routine examination. Immunological studies revealed the expansion of granular lymphocytes (GL) with the following, previously undescribed phenotype: Leu 7+, OKT3+, OKT4+, OKT8-, OKM1+. These cells were tested for their functional activities and found to exert neither helper nor suppressor functions in in vitro tests. Cytotoxic activities demonstrated a strong ADCC and a markedly reduced NK function. 1 year later the clinical course has remained good without any treatment and we suggest that this case should be classified as an abnormal expansion of GL, despite the OKT4 positivity of the cells. Our data point out the importance of a careful immunological study of cells from these rare patients and suggest the existence of a normal GL population expressing the OKT4 phenotype, which is possibly expanded in this patient.
In Vitro Cellular & Developmental Biology – Plant | 1980
F Pandolfi; Douglas M. Strong; Guy D. Bonnard; Ronald B. Herberman
SummaryFour hematopoietic cell lines (CCRF-CEM, HSB-2, MOLT-4, and RPMI-8402), derived from acute lymphoblastic leukemia and expressing T-cell surface markers (T-HCL), were studied with two specific anti-T-cell sera. The sera were raised in rabbits against human thymocytes (anti-HTY) and against T-cells cultured in the presence of conditioned medium derived from lymphocytes stimulated with PHA (anti-CTC). Both sera were absorbed to obtain a T-cell specific pattern of reaction and were further absorbed with normal peripheral blood lymphocytes or with each of the four T-HCL. The anti-HTY sera absorbed with CEM, 8402, and HSB-2 still reacted with MOLT-4. A similar pattern of reactivity was found only with the anti-CTC absorbed with 8402, whereas, after absorptions with the other cell lines, this antiserum was unreactive against MOLT-4. After absorption with normal peripheral blood lymphocytes, anti-HTY still reacted with thymocytes and MOLT-4 but was negative on CTC. In contrast, anti-CTC absorbed with peripheral blood lymphocytes (PBL) was negative on thymocytes and MOLT-4 but still reacted against CTC. Our data confirm the existence of a T-cell antigen (probably an early T-cell differentiation antigen) shared between thymus and MOLT-4. This antigen is not expressed on CTC, although these cells express an antigenic pattern more complex than PBL. Antisera to CTC represents a source of anti-T-cell sera free of contamination with antibodies to early thymus-related antigens but containing other T-cell-related specificities.
Cancer | 1990
F Pandolfi; T. P. Loughran; G. Starkebaum; Teodoro Chisesi; Tiziano Barbui; W. C. Chan; J. C. Brouet; G. De Rossi; Robert W. McKenna; F. Salsano; F. Herrmann; J. W. Vanoostveen; G. Schlimok; A. Cafaro; Renato Zambello; M. C. Garcia Rodriguez; C. H. Geisler; Giovanni Pizzolo; R. G. Steis; J. U. Brisbane; M. E. Kadin; Alberto Mantovani; S. Tagawa; A. S. Fauci; G. Gastl; M. Palutke; S. J. Proctor; H. F. Pross; P. Mancini; Fernando Aiuti
Blood | 1982
F Pandolfi; G. De Rossi; G. Semenzato; I Quinti; A Ranucci; G. De Sanctis; Manuela Lopez; G Gasparotto; Fernando Aiuti
Blood | 1984
Gianpietro Semenzato; G. Pizzolo; A Ranucci; Carlo Agostini; M Chilosi; I Quinti; G. De Sanctis; B Vercelli; F Pandolfi
Clinical and Experimental Immunology | 1983
F Pandolfi; G. Semenzato; G de Rossi; I Quinti; Cesare Guglielmi; A. Pezzutto; Manuela Lopez; G Tonietti; L. Fontana; T Abo; Fernando Aiuti
The Lancet | 1982
F Pandolfi; WilliamA. Blattner; Giulio Rossi; Gianpietro Semenzato; DouglasM. Strong; Robert C. Gallo
Archive | 2011
F Pandolfi; G De Rossi; A Ranucci; G Bonomo; Daniela Pasqualetti; M Napolitano; Vittorio Manzari
Archive | 2011
F Pandolfi; G. Semenzato; I Quinti; A Ranucci; G De Sanctis; Manuela Lopez; G Gasparotto